Meal type and size are the key factors affecting carb-counting in type 1 diabetes

September 16, 2019

Meal type and size are the most important factors influencing the accuracy of carb-counting for the control of blood sugar in type 1 diabetes, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Spain (16-20 September).

The results highlight the need for better information to help people with type 1 diabetes improve the accuracy of their carb-counting and reduce the risk of hypoglycemia (low blood glucose levels) that can lead to cognitive decline, cardiovascular events, and even death, researchers say.

People living with type 1 diabetes must manage their daily carbohydrate intake to keep glucose levels in check. Most carbohydrates are converted into glucose and directly affect blood sugar levels. Carbohydrate counting is widely used as a way of matching insulin requirements with the amount of carbs consumed.

However, errors in carb-counting are common and can be critical. Underestimating meal carbohydrate content can raise the amount of sugar in the bloodstream leading to hyperglycemia (high blood sugar), while carbohydrate overestimation can cause hypoglycemia (low blood sugar).

To investigate which factors affect carb-counting errors most, researchers analysed data on 50 adults with type 1 diabetes from a previously published study of carbohydrate counting accuracy [1]. Over 3 days, participants estimated the amount of carbohydrate in their meals. To determine participant's carb-counting error, the carbohydrate content of each meal was also calculated by a dietitian.

Researchers then used modelling to identify which patient- and meal-related factors had an effect on carb-counting error. These included a participant's level of education, duration of insulin treatment, age, body weight, meal's carbohydrate, fat, energy, protein, and fibre content, and type of meal (i.e., breakfast, lunch, dinner, or snack).

They found that carbohydrate content and meal type were the most important factors influencing the accuracy of carb counting. Specifically, participants made more carb-counting errors for larger meals (i.e. lunch and dinner), and smaller errors for smaller meals (i.e. breakfast and snacks).

"Glucose control around meal times remains challenging for people with type 1 diabetes. Our findings underscore the need for better information to help patients better estimate the carbohydrate content of their meals", says author Dr Martina Vettoretti from the University of Padova in Italy, where the research was conducted as part of the ongoing European research project Hypo-RESOLVE.

"Once included in type 1 diabetes computer simulations, our model will enable researchers to assess the impact of carb-counting error on blood sugar control and, more in general, to help study behavioural risk factors for hypoglycemia and assess the potential benefits of addressing them."
-end-


Diabetologia

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.